(NASDAQ: ASRT) Assertio Holdings's forecast annual revenue growth rate of -6.55% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 3.11%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 59.69%.
Assertio Holdings's revenue in 2025 is $124,961,000.On average, 2 Wall Street analysts forecast ASRT's revenue for 2025 to be $11,183,901,767, with the lowest ASRT revenue forecast at $10,793,626,454, and the highest ASRT revenue forecast at $11,574,177,081.
In 2026, ASRT is forecast to generate $12,824,015,814 in revenue, with the lowest revenue forecast at $12,661,201,573 and the highest revenue forecast at $12,986,830,055.